openPR Logo
Press release

Valuation Of Oncology Molecular Diagnostics Is Anticipated To Reach At US$ 4 Billion By 2031

01-30-2023 01:50 PM CET | Health & Medicine

Press release from: Fact.MR

Valuation Of Oncology Molecular Diagnostics Is Anticipated

The market for cancer molecular diagnostics was estimated to be around US$ 1.7 billion in 2020 and is projected to be worth US$ 4 billion by 2031.
The increased incidence of infectious diseases and cancer, expanding R&D spending, growth in PoC (point of care) testing equipment, and numerous technological breakthroughs all contribute to the demand for oncology molecular diagnostics.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜: https://www.factmr.com/connectus/sample?flag=S&rep_id=6864?PS

The Oncology Molecular Diagnostics Market research offers a thorough analysis of the business models, important market dynamics, including the drivers, restraints, trends, and opportunities, key business models, and respective market shares of some of the leading key players in the market. Along with an in-depth analysis of the major driving factors, the detailed research provides market data in terms of revenues, segment-specific data, regional data, and territorial data. Providing unique information about the market's anticipated growth from 2022 to 2028 is the primary goal of the Oncology Molecular Diagnostics Market report.

This industry's supply chain, from upstream raw materials to downstream consumers, will be the subject of scientific investigation. In the interim, the feature of the product circulation and sales channel will be emphasised. Simply said, this research will assist you in developing a broad view on the characteristics of the Oncology Molecular Diagnostics Market.

๐—ž๐—ฒ๐˜† ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ๐—ฑ

โ€ข F. Hoffmann-La Roche Ltd
โ€ข Hologic
โ€ข BioMรฉrieux SA
โ€ข Abbott Laboratories
โ€ข QIAGEN
โ€ข Thermo Fisher Scientific Inc.
โ€ข Siemens Healthineers AG
โ€ข Danaher Corporation
โ€ข Myriad Genetics Inc.
โ€ข Illumina Inc.
โ€ข Agilent Technologies Inc.
โ€ข Becton
โ€ข Dickinson and Company

By Region

โ€ข North America [United States, Canada, Mexico]
โ€ข South America [Brazil, Argentina, Columbia, Chile, Peru]
โ€ข Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
โ€ข Middle East & Africa [GCC, North Africa, South Africa]
โ€ข Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6864?PS

One of the key reasons influencing the growth of the global market is the rising prevalence of cancer as a result of changing lifestyles, an ageing population, and an increase in smoking.

In addition, the market is expanding as a result of rising demand for quick and precise diagnoses and improvements in next-generation sequencing (NGS) methods for oncology molecular diagnostics.

Additionally, an increase in the number of people with bacterial and viral infections and a rise in the number of people taking part in blood donation drives are both boosting demand for cancer molecular diagnostic tests globally.

๐—ž๐—ฒ๐˜† ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—•๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜๐˜€:

โ€ข The report will help in developing business strategies by understanding the trends shaping and driving the global Oncology Molecular Diagnostics Market.
โ€ข Organize sales and marketing efforts by identifying the best opportunities for Oncology Molecular Diagnostics in the US, Europe, and Japan.
โ€ข To understand the future market competition and insightful review of the key market drivers and barriers.
โ€ข To understand the regulatory scenario in major markets.

The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

๐—ž๐—ฒ๐˜† ๐—›๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ง๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ผ๐—ณ ๐—–๐—ผ๐—ป๐˜๐—ฒ๐—ป๐˜๐˜€:

โ€ข Study Coverage: It covers important market segments, prominent manufacturers, the range of goods offered throughout the years under consideration, the global market for anti-snoring devices and surgery, and the study's objectives. It also discusses the segmentation analysis based on product type and applications that is presented in the report.
โ€ข Executive summary: In addition to the macro indicators, this section stresses the major studies, market growth rate, competitive landscape, market drivers, trends, and concerns.
โ€ข by Region: This section of the report includes data on import and export, revenue, production, and important players in each of the geographical markets under study.
โ€ข Profile of Manufacturers: This section goes into great detail about each market participant that is profiled. Additionally, the SWOT analysis, products, production, value, capacity, and other crucial elements of each player are included in this section.

๐—š๐—ฒ๐˜ ๐—™๐˜‚๐—น๐—น ๐—”๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€ ๐—ผ๐—ณ ๐—–๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:
https://www.factmr.com/checkout/6864

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ถ๐—ป ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐— ๐—ผ๐—น๐—ฒ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

By Product

โ€ข Oncology Molecular Diagnostic Reagents & Kits
โ€ข Oncology Molecular Diagnostic Instruments
โ€ข Oncology Molecular Diagnostic Tabletop Instruments
โ€ข Oncology Molecular Diagnostic Portable & PoC Instruments
โ€ข Oncology Molecular Diagnostic Services & Software

By Technology

โ€ข Polymerase Chain Reaction (PCR) in Oncology Molecular Diagnostics
โ€ข Isothermal Nucleic Acid Amplification Technology (INAAT) for Oncology Molecular Diagnostics
โ€ข DNA Sequencing & Next-Generation Sequencing (NGS) for Oncology Molecular Diagnostics
โ€ข In Situ Hybridization (ISH) Technology for Oncology Molecular Diagnostics
โ€ข DNA Chips and Microarrays for Oncology Molecular Diagnostics

By End User

โ€ข Oncology Molecular Diagnostic Used in Diagnostic Laboratories
โ€ข Oncology Molecular Diagnostic Used in Hospitals & Clinics

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Valuation Of Oncology Molecular Diagnostics Is Anticipated To Reach At US$ 4 Billion By 2031 here

News-ID: 2904687 • Views: โ€ฆ

More Releases from Fact.MR

Ice Skating Equipment Market worth is poised to reach US$ 1478 Billion in 2033
03-28-2024 | Sports
Fact.MR
Ice Skating Equipment Market worth is poised to reach US$ 1478 Billion in 2033
The global ice skating equipment market garnered a market value of US$ 6.87 Billion in 2022 and is expected to accumulate a market value of US$ 16.26 Billion by registering a CAGR of 9% in the forecast period 2023-2033. Ice skating is a popular activity observed in numerous snow-clad regions around the world, serving various purposes including exercise, leisure, and excitement. This recreational pursuit can occur in specially prepared ice arenasโ€ฆ
Global Barcode Software Market is predicted to be valued at US$ 1.4 Billion by 2032
Global Barcode Software Market is predicted to be valued at US$ 1.4 Billion by 2 โ€ฆ
The barcode software market is predicted to grow at a moderate CAGR of 6.3% over the forecast period of 2022 to 2032. The barcode software market is estimated to achieve a net worth of about US$ 1.4 Billion in the year 2032, improving from US$ 694.9 Million recorded in 2021. For more insights into the Market, Get A Sample of this Report! https://www.factmr.com/connectus/sample?flag=S&rep_id=7368 The barcode software market emerges as a crucial enabler ofโ€ฆ
Hardware Acceleration is forecasted to accelerate at a commendable CAGR of 51% from 2023 to 2033
Hardware Acceleration is forecasted to accelerate at a commendable CAGR of 51% f โ€ฆ
The global hardware acceleration market stands at US$ 2.87 billion in 2023. Worldwide demand for hardware acceleration technology is projected to skyrocket at a CAGR of 51% and reach a market value of US$ 177 billion by 2033. Hardware acceleration refers to the use of specialized hardware components to perform specific tasks more efficiently than general-purpose processors. This technology has gained significant traction across various industries due to its ability toโ€ฆ
03-28-2024 | Food & Beverage
Fact.MR
Marine Collagen Ingredients Market value is projected to reach US$ 2,320.6 milli โ€ฆ
According to Fact.MR analysis, the marine collagen ingredients market is poised for steady growth in the coming years. The market's overall value is anticipated to exceed US$ 2,320.6 million by the year 2033, a significant increase from US$ 1,076.8 million recorded in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 8.0% during the assessment period spanning from 2023 to 2033. Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8704 In recentโ€ฆ

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and isโ€ฆ
Global Tissue Diagnostic Market 2020 Business Strategies โ€“ Roche Diagnostic, A โ€ฆ
The Zion Market Research added a new report โ€œTissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017โ€ฆ
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca โ€ฆ
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trendsโ€ฆ
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn โ€ฆ
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation onโ€ฆ
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPVโ€ฆ
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 โ€ฆ
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of theโ€ฆ